{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:07:42Z","timestamp":1767136062296,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009361","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000}}],"reference-count":74,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009361.pub2","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T19:07:47Z","timestamp":1354820867000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Colesevelam for type 2 diabetes mellitus"],"prefix":"10.1002","volume":"2012","author":[{"given":"Cheow Peng","family":"Ooi","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Sciences, Universiti Putra Malaysia; Endocrine Unit, Department of Medicine; Serdang Selangor DE Malaysia 43400"},{"name":"Universiti Putra Malaysia; Institute of Gerontology; Serdang Selangor DE Malaysia 43400"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng Cheong","family":"Loke","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sciences, Universiti Putra Malaysia; Endocrine Unit, Department of Medicine; Serdang Selangor DE Malaysia 43400"},{"name":"Universiti Putra Malaysia; Institute of Gerontology; Serdang Selangor DE Malaysia 43400"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"issue":"18","key":"10.1002\/14651858.CD009361.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/archinte.168.18.1975","article-title":"Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects","volume":"168","author":"Bays","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD009361.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc08-0283","article-title":"Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy","volume":"31","author":"Fonseca","year":"2008","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1002\/14651858.CD009361.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archinte.168.14.1531","article-title":"Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy","volume":"168","author":"Goldberg","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009361.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4158\/EP10130.OR","article-title":"Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes","volume":"16","author":"Rosenstock","year":"2010","journal-title":"Endocrine Practice"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/met.2009.0049","article-title":"The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study","volume":"8","author":"Schwartz","year":"2010","journal-title":"Metabolic Syndrome and Related Disorders"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2008.09.026","article-title":"Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes","volume":"204","author":"Rosenson","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD009361.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clinthera.2007.01.003","article-title":"Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes","volume":"29","author":"Zieve","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD009361.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0029-1241195","article-title":"Long-term safety and tolerability of colesevelam HCl in subjects with type 2 diabetes","volume":"42","author":"Goldfine","year":"2010","journal-title":"Hormone & Metabolic Research"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1463-1326.2009.01159.x","article-title":"Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study","volume":"12","author":"Kondo","year":"2010","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"9603","key":"10.1002\/14651858.CD009361.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(07)61696-1","article-title":"The burden and costs of chronic diseases in low-income and middle-income countries","volume":"370","author":"Abegunde","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009361.pub2-BIB0011|cit11","first-page":"S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"22","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1999","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009361.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","article-title":"Standards of medical care in diabetes - 2008","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009361.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes - 2011","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ije\/dyr029","article-title":"Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis","volume":"40","author":"Agardh","year":"2011","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0015|cit15","first-page":"779","article-title":"Colesevelam HCl: a non-systemic lipid-altering drug","volume":"4","author":"Bays","year":"2003","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1742-1241.2007.01336.x","article-title":"The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys","volume":"61","author":"Bays","year":"2007","journal-title":"International Journal of Clinical Practice"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0091270009349378","article-title":"Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide","volume":"50","author":"Brown","year":"2010","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0018|cit18","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro. Version 3.2 for Windows 2008"},{"issue":"1","key":"10.1002\/14651858.CD009361.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.transproceed.2010.09.098","article-title":"Epidemiology and costs of diabetes","volume":"43","author":"Bruno","year":"2011","journal-title":"Transplantation Proceedings"},{"issue":"20","key":"10.1002\/14651858.CD009361.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2008.09.047","article-title":"Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006","volume":"122","author":"Cheung","year":"2009","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD009361.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"9435","key":"10.1002\/14651858.CD009361.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1377\/hlthaff.2009.0155","article-title":"The economic burden of diabetes","volume":"29","author":"Dall","year":"2010","journal-title":"Health Affairs"},{"issue":"16","key":"10.1002\/14651858.CD009361.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1001\/archinte.159.16.1893","article-title":"Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects","volume":"159","author":"Davidson","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009361.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1987","journal-title":"Diabetes"},{"issue":"7","key":"10.1002\/14651858.CD009361.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s10620-005-2765-8","article-title":"Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia","volume":"50","author":"Donovan","year":"2005","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009361.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7010","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study","volume":"7","author":"Egger","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0030|cit30","unstructured":"Cholestagel, INN-Colesevelam European Medicine Agency 2005 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_ _Scientific_Discussion\/human\/000512\/WC500025676.pdf"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1463-1326.2009.01181.x","article-title":"Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence","volume":"12","author":"Fonseca","year":"2010","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD009361.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD009361.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009361.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/jps.20734","article-title":"Bile acid salt binding with colesevelam HCl is not affected by suspension in common beverages","volume":"95","author":"Hanus","year":"2006","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.23408","article-title":"Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice","volume":"51","author":"Herrema","year":"2010","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0040|cit40","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7","key":"10.1002\/14651858.CD009361.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO Journal"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0042|cit42","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2009"},{"issue":"10","key":"10.1002\/14651858.CD009361.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4065\/76.10.971","article-title":"Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial","volume":"76","author":"Insull","year":"2001","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.smj.0000208120.73327.db","article-title":"Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review","volume":"99","author":"Insull","year":"2006","journal-title":"Southern Medical Journal"},{"issue":"6A","key":"10.1002\/14651858.CD009361.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"47C","DOI":"10.1016\/j.amjcard.2006.11.022","article-title":"Safety considerations with gastrointestinally active lipid-lowering drugs","volume":"99","author":"Jacobson","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/dc09-1597","article-title":"Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006","volume":"33","author":"Kalyani","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/02813430600819710","article-title":"Inadequate treatment of dyslipidemia in people with type 2 diabetes: quality assessment of diabetes care in a Danish County","volume":"24","author":"Kolding Kristensen","year":"2006","journal-title":"Scandinavian Journal of Primary Health Care"},{"issue":"4","key":"10.1002\/14651858.CD009361.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.99.4.461","article-title":"Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study","volume":"99","author":"Laakso","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD009361.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"1999","journal-title":"PLoS Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009361.pub2-BIB0052|cit52","first-page":"e46","article-title":"Heart disease and stroke statistics - 2010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD009361.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/jc.2004-0699","article-title":"Sulfonylurea induced beta-cell apoptosis in cultured human islets","volume":"90","author":"Maedler","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.0000049640.46039.52","article-title":"Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes","volume":"107","author":"Mehler","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"25","key":"10.1002\/14651858.CD009361.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"NCEP","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0057|cit57","unstructured":"National Institute of Diabetes Digestive Kidney Disorders (NIDDKD) National Diabetes Information Clearinghouse (NDIC): National Diabetes Statistics fact sheet, 2011. www.cdc.gov\/diabetes\/pubs\/pdf\/ndfs_2011.pdf (accessed 23 October 2012)"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0058|cit58","first-page":"173","article-title":"Burden of diabetes in the adult Chinese population: a systematic literature review and future projections","volume":"3","author":"Pan","year":"2010","journal-title":"International Journal of General Medicine"},{"issue":"9590","key":"10.1002\/14651858.CD009361.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD009361.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"23","key":"10.1002\/14651858.CD009361.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1002\/sim.1078","article-title":"Use of the equivalence approach in reproductive health clinical trials","volume":"20","author":"Piaggio","year":"2001","journal-title":"Statistical Medicine"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0062|cit62","volume-title":"Clinical Trials. A Practical Approach. 2","author":"Pocock","year":"1991"},{"issue":"5","key":"10.1002\/14651858.CD009361.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/js9603820","article-title":"Absorption, distribution and excretion of GT31-104, a novel bile acid sequestrant, in rats and dogs after acute and subchronic administration","volume":"86","author":"Rosenbaum","year":"1997","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2005.05.032","article-title":"Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia","volume":"185","author":"Rosenson","year":"2006","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1002\/14651858.CD009361.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1074\/jbc.M110.116004","article-title":"Regulation of bile acid synthesis by fat-soluble vitamins A and D","volume":"285","author":"Schmidt","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32 Suppl 2","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/9780470693926.ch11","article-title":"Investigating and dealing with publication and other biases","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Sterne","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2010.05.009","article-title":"The socioeconomics of diabetes from a developing country: a population based cost of illness study","volume":"89","author":"Tharkar","year":"2010","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"7160","key":"10.1002\/14651858.CD009361.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ (Clinical Research ed)"},{"issue":"7","key":"10.1002\/14651858.CD009361.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2337\/diacare.22.7.1125","article-title":"Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37)","volume":"22","author":"UK Prospective Diabetes Study Group","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD009361.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabetic Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009361.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehr205","article-title":"Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study","volume":"33","author":"Yang","year":"2012","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD009361.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Research and Clinical Practice"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009361.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T14:22:12Z","timestamp":1727533332000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009361.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Metabolic and Endocrine Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":74,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009361.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}